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The stability of expression of an internal control is
required for accurate and reliable normalization in quanti-
tative real-time reverse transcription–polymerase chain
reaction (qRT-PCR) experiments. However, expression of
commonly used reference genes can be regulated under
specific experimental conditions, particularly in response
to stimuli that exert multiple effects on gene expression.
The neurotrophin brain-derived neurotrophic factor
(BDNF) regulates gene expression through activation of
multiple signaling cascades, and we have conducted an
expression study for the proper validation of internal con-
trol genes in BDNF-stimulated cultured hippocampal
neurons. geNorm and NormFinder were applied to eight
potential genes to identify the most stable genes to be
used in the relative quantification of the effects of BDNF
on gene expression. Our data show that Tbp (TATA box
binding protein), Ppia (peptidylprolyl isomerase A), Pgk1
(phosphoglycerate kinase 1), and Hprt1 (hypoxanthine
guanine phosphoribosyl transferase I) are the most stable
genes under the experimental conditions used, contrast-
ing with Tuba1 (tubulin alpha1-A chain) and Gapdh
(glyceraldehydes-3-phosphate dehydrogenase), two
genes widely used as control genes, which showed an
unstable expression in hippocampal neurons stimulated
with BDNF. Analysis of the BDNF-induced changes in
expression of Sars, Tufm, and Egr3 by using different
sets of control genes showed distinct results, with a
combination of three to four of the genes Tbp/Ppia/Pgk1/
Hprt1 providing the most consistent results. Our data
reinforce the need for proper validation of the internal
control genes for an accurate quantification of qRT-PCR
results, particularly when analyzing cellular responses to
agents (e.g., neurotrophins) that cause multiple changes
in gene expression. VC 2008 Wiley-Liss, Inc.
Key words: brain-derived neurotrophic factor; quanti-
tative real-time reverse transcription–PCR; internal control
gene; normalization
Neurotrophins play important roles in the regula-
tion of axonal and dendritic growth and guidance, syn-
aptic structure and connections, short- and long-term
changes in synaptic activity, and neuronal survival and
neuroprotection (Huang and Reichardt, 2001; Chao,
2003; Almeida et al., 2005; Schweigreiter, 2006; Cal-
deira et al., 2007; Manadas et al., 2007; Carvalho et al.,
2008). Furthermore, neurotrophins contribute to glial
cell development and survival (Althaus and Richter-
Landsberg, 2000; Schweigreiter, 2006; Manadas et al.,
2007). Brain-derived neurotrophic factor (BDNF) is
the most widely distributed neurotrophin in the adult
brain, acting through the activation of the Trk (tropo-
myosin-related kinase) B and p75 neurotrophin recep-
tors (Chao, 2003; Reichardt, 2006; Manadas et al.,
2007). Binding of BDNF to the TrkB receptors leads
to their dimerization and transphosphorylation on
tyrosine residues, allowing the interaction with adaptor
proteins and signaling enzymes. TrkB receptors are
coupled to the activation of extracellular signal-regu-
lated kinases, members of the mitogen-activated protein
kinase family, and of phospholipase C-g and phosphati-
dylinositol 3-kinase (PI3-K). Phospholipase C-g gener-
ates diacylglycerol and inositol 1,4,5-trisphosphate, and
PI3-K leads to the activation of Akt/PKB (Almeida
et al., 2005; Reichardt, 2006; Manadas et al., 2007).
Each one of the signaling pathways activated by TrkB
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receptors may affect transcription activity (Finkbeiner
et al., 1997; Datta et al., 1999; Reichardt, 2006), lead-
ing to a complex program of changes in gene expres-
sion, as observed in the mouse brain (Koponen et al.,
2004), in cultured hippocampal neurons (Ring et al.,
2006), and in a neuroblastoma cell line (Schulte et al.,
2005). The multiple effects of TrkB receptor on tran-
scription activity partly accounts for the diversity of
functional roles of BDNF, including its role in synaptic
plasticity (reviewed by Carvalho et al., 2008). The role
played by BDNF in numerous neurological disorders
(Hashimoto et al., 2005; Chao et al., 2006) may also
involve transcription-dependent mechanisms.
Quantitative real-time reverse transcription–poly-
merase chain reaction (qRT-PCR) is a powerful tech-
nique broadly used for mRNA quantification (Dheda
et al., 2005; Huggett et al., 2005). Because there are
several steps in qRT-PCR that may show variations
between genes and samples, such as reverse transcription
and the qPCR reaction (Pfaffl, 2001; Ramakers et al.,
2003), the results are usually normalized in order to allow
accurate comparisons between samples. Several normaliza-
tion strategies have been proposed, being normalization
with internal controls the most widely used (Pfaffl, 2004;
Bustin et al., 2005). Endogenous controls, commonly
named as reference genes, are subjected to the same condi-
tions as the target genes, and their expression is also meas-
ured by qRT-PCR (Suzuki et al., 2000). An ideal refer-
ence gene shows an invariable and constant expression
among different tissues, independently of the experimental
setup. Moreover, the expression level of the endogenous
control should preferentially be similar to that of the target
genes (Pfaffl, 2004; Sindelka et al., 2006). Although varia-
tions in the expression of reference genes may compro-
mise the normalization procedure (Vandesompele et al.,
2002; Bustin et al., 2005; Dheda et al., 2005), the com-
monly accepted reference genes are often used without
proper verification of their expression stability under the
specific experimental conditions used. For example, b-
actin and glyceraldehyde-3-phosphate-dehydrogenase are fre-
quently used for normalization of gene expression data,
although their expression may change with cell prolifera-
tion and differentiation (Bustin, 2000; Goidin et al., 2001;
Glare et al., 2002; Schmittgen and Zakrajsek, 2000; Zhu
and Altmann, 2005; Sindelka et al., 2006, 2007). There-
fore, b-actin and glyceraldehyde-3-phosphate-dehydrogenase
expression may be unsuitable as endogenous controls for
qRT-PCR, at least for certain experimental protocols.
Inaccurate normalization leads in inadequate quantifica-
tion of mRNA levels and spurious conclusions (de Kok
et al., 2005).
The use of endogenous control genes allows for
the correction of experimental variations, such as in
sample extraction, quantification, and reverse transcrip-
tion reaction efficiency (Pfaffl, 2004; Kubista et al.,
2007). The available evidence indicates that there are no
universal reference genes (Huggett et al., 2005), and
therefore, the endogenous control genes have to be
selected for each specific experimental condition (Pfaffl
et al., 2004). A reliable and accurate quantification of
mRNA expression requires a prior and proper validation
of suitable endogenous control genes (Vandesompele
et al., 2002; Andersen et al., 2004), and this is particu-
larly relevant in studies addressing the expression of
genes that show small changes for the experimental con-
ditions under investigation.
This study aimed at identifying proper endogenous
control genes for normalization of gene expression in
BDNF-stimulated neurons. For this purpose, a panel of
eight potential endogenous control genes was tested
regarding their expression in BDNF-stimulated cells.
Although several tools to identify the most stably
expressed genes in a specific setup have been developed,
none is universally accepted. Therefore, the potential
endogenous control genes were tested by two different
software packages, geNorm (Vandesompele et al., 2002)
and NormFinder (Andersen et al., 2004), both available
in the GenEx package software (MultiD Analyses, Swe-
den). Our results show that a careful validation of the
reference genes used in the normalization of qRT-PCR
data is needed for an accurate quantification of changes
in gene expression.
MATERIALS AND METHODS
Hippocampal Cultures
Primary cultures of rat hippocampal neurons were pre-
pared from the hippocampi of E18–E19 Wistar rat embryos
after treatment with trypsin (0.06%) for 15 min at 378C
(Gibco Invitrogen, Paisley, United Kingdom) and deoxyribo-
nuclease I (5.36 mg/mL), in Ca21- and Mg21-free Hanks’
balanced salt solution (HBSS), as previously described (Cal-
deira et al., 2007). The hippocampi were then washed with
HBSS containing 10% fetal bovine serum (BioWittaker
Europe, Belgium) to stop trypsin activity, and transferred to
Neurobasal medium (Gibco Invitrogen) supplemented with
B27 supplement (1:50 dilution; Gibco Invitrogen), 25 lM
glutamate, 0.5 mM glutamine, and 0.12 mg/mL gentamycin.
The cells were dissociated in this solution and were plated in
six-well plates coated with poly-D-lysine (0.1 mg/mL). The
cultures were maintained in a humidified incubator of 5%
CO2/95% air at 378C for 7 days. Cultures were stimulated
with 100 ng/mL BDNF (Peprotech, London, United King-
dom) for 30 min or 3 hr.
Total RNA Isolation, RNA Quality, and
RNA Concentration
Total RNA from seven DIV-cultured hippocampal
neurons was extracted with TriZol reagent (Invitrogen,
Barcelona, Spain), following the manufacturer’s specifications.
The full content of a six-well cluster plate, with a density of
850,000 cells/mL, was collected for each experimental condi-
tion. After the addition of chloroform and phase separation,
the RNA was precipitated by the addition of isopropanol.
The precipitated RNA was washed once with 75% ethanol,
centrifuged, air dried, and resuspended in 60 lL of RNase-
free water (Gibco Invitrogen). The whole procedure was per-
formed at 48C.
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RNA quality and integrity was assessed by the Experion
automated gel electrophoresis system (Bio-Rad, Amadora,
Portugal). A virtual gel was created for each sample, allowing
the detection of degradation of the reference markers RNA
18S and 28S. Samples showing RNA degradation or contami-
nation by DNA were discarded. RNA concentration was
determined by the fluorescent dye Ribogreen (Invitrogen–
Molecular Probes). The samples were formed into aliquoted
and stored at 2808C until further use.
Reverse Transcription
For first-strand cDNA synthesis, 1 lg of total RNA was
mixed with Random Hexamer Primer p(dN)6 followed by
10 min denaturation at 658C to ensure loss of secondary struc-
tures that may interfere with the annealing step. The samples
were chilled on ice, and the template–primer mix was then
supplemented with reaction buffer (50 mM Tris/HCl, 30 mM
KCl, 8 mM MgCl2, pH 8.5), Protector RNase Inhibitor (20
U), dNTPs (1 mM each), and finally AMV Reverse Tran-
scriptase (10 U; Roche, Carnaxide, Portugal) in a 20 lL final
volume. The reaction was performed at 258C for 10 min, fol-
lowed by 30 min at 558C, for primer annealing to the tem-
plate and cDNA synthesis, respectively. The reverse transcrip-
tase was then denatured for 5 min at 858C, and the sample
was then cooled to 48C for 5 min, and finally stored at
2808C until further use.
Primer Design
Primers for real-time PCR were designed by Beacon
Designer 7 software (Premier Biosoft International, Palo Alto,
CA), and the following considerations were taken: 1) GC
content about 50%; 2) annealing temperature (Ta) between
55 6 58C; 3) secondary structures and primers–dimers were
avoided; 4) primer length 18–24 bp; 5) final product length
100–200 bp.
Real-Time PCR
For gene expression analysis, 2 lL of 1:100 diluted
cDNA was added to 10 lL 23 SYBR Green Master Mix
(Bio-Rad), and the final concentration of each primer was
250 nM in 20 lL total volume. The thermocycling reaction
was initiated with activation of Taq DNA polymerase
by heating at 958C during 30 sec, followed by 45 cycles of a
10-sec denaturation step at 958C, a 30 sec annealing step at
538C, and a 30 sec elongation step at 728C. The fluorescence
was measured after the extension step by the iQ5 Multicolor
Real-Time PCR Detection System (Bio-Rad). After the ther-
mocycling reaction, the melting step was performed with slow
heating, starting at 558C and with a rate of 0.58C per 10 sec,
up to 958C, with continuous measurement of fluorescence,
allowing detection of possible nonspecific products. The assay
included a nontemplate control and a standard curve (in 10-
fold steps) of cDNA for assessing the efficiency of each set of
primers. All reactions were run in duplicate to reduce con-
founding variance.
Data Processing
The threshold cycle (Ct) represents the detectable fluo-
rescence signal above background resulting from the accumu-
lation of amplified product, and is a proportional measure of
the starting target sequence concentration. Ct was measured in
the exponential phase and therefore was not affected by possi-
ble limiting components in the reaction. For every run per-
formed, Ct was set at the same fluorescence value.
Data analysis was performed by GenEx (MultiD Analy-
ses) software for real-time PCR expression profiling, which
contains both geNorm and NormFinder algorithms. This soft-
ware enables further determination of the optimal number of
endogenous control genes by using the NormFinder algo-
rithm. Because geNorm can only work on linear data, Ct val-
ues from qRT-PCR were converted into relative quantities
by the appropriate tool available in the GenEx software (Ct
values were calculated as a fraction of the maximum value).
Where indicated, statistical analysis of the log-transformed
expression data was performed by the Student’s t-test.
RESULTS
To identify the best internal control genes in
BDNF-stimulated hippocampal neurons, the expression
of eight commonly used reference genes (Gapdh, glycer-
aldehyde-3-phosphate dehydrogenase; Actb, b-actin
zipcode binding protein 1; Tuba1, tubulin alpha1-A
chain; rRNA18S, 18S rRNA gene; Pgk1, phosphogly-
cerate kinase 1; Tbp, TATA box binding protein; Ppia,
peptidylprolyl isomerase A; and Hprt1, hypoxanthine
guanine phosphoribosyl transferase I) was evaluated (de
Kok et al., 2005; Jung et al., 2007). Table I provides in-
formation about the primers and reference and target
genes. All reference genes have known functions in the
cell, ranging from glycolysis (Gapdh and Pgk1), cytoske-
letal protein (Actb), cell mobility (Tuba1), regulation of
transcription (Tbp), protein folding and transport
(Ppia), purine metabolism (Hprt1), and protein synthesis
(rRNA 18S).
The eight reference genes tested show different
expression levels in cultured hippocampal neurons, as
determined by the average threshold cycle (Ct) for the
selected fluorescence intensity (Fig. 1). rRNA 18S shows
the highest expression level, corresponding to an early
Ct value, whereas Actb displays the lowest expression
levels, with a late Ct value. However, none of the genes
showed a constant expression on BDNF stimulation, as
observed in the scatterplot shown in Figure 1. It was
thus inaccurate to randomly pick up a given set of genes
and use them as stable reference genes, so we further
investigated the expression stability of the selected genes
in hippocampal neurons on BDNF stimulation by geN-
orm (Vandesompele et al., 2002) and NormFinder
(Andersen et al., 2004) algorithms. These applications
allow checking for the stability of endogenous control
genes.
geNorm (Vandesompele et al., 2002) is based in an
algorithm that ranks all tested genes according to their
stability in every sample tested (control, and samples
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treated with BDNF for 30 min or 3 hr). This algorithm
selects the best two internal control genes for a given
experimental setup since it is based on the assumption
that if the expression of two genes is constant, its ratio
should be constant across all samples. Therefore, this
method leads to the selection of gene pairs with similar
expression patterns. The algorithm calculates an expres-
sion stability value (M) during stepwise exclusion of the
least stable control gene, with the highest M values corre-
sponding to the least stable genes, and vice versa. From
the list of eight tested genes, geNorm selected Ppia and
Hprt1 as the most stable genes in samples from control
and BDNF-treated hippocampal neurons (Fig. 2); these
two genes showed a similar expression pattern in the sam-
ples used (Fig. 1). Tuba1 and Gapdh were the most vari-
able genes, corresponding to the highest M values.
The geNorm application also determines the opti-
mal number of internal control genes by using the nor-
malization factor (NF), which is based on the geometric
mean of the expression levels of the best endogenous
control genes, calculated by the stepwise inclusion of the
following best-ranked endogenous gene (Vandesompele
et al., 2002). The NF is a useful tool for the determina-
tion of the optimal number of control genes because the
effect of the additional gene will be reflected in the NF.
In this analysis, the number of control genes necessary
for an accurate normalization process is achieved when
the addition of a new gene does not greatly influence
the NF. Figure 3 shows the multiple NF values calcu-
lated from the stepwise inclusion of the best ranked
gene. The addition of the third best gene—Pgk1—raised
the NF to 0.21 (V2/3), and the addition of the fourth
best control gene, Tbp, reduced the NF (V3/4 5 0.18).
Since Tbp did not greatly affect NF, it can be excluded
from the normalization process because its addition will
not improve the analysis. Addition of the most variable
genes, Tuba1 and Gapdh, increased the NF (V6/7 5
0.22 and V7/8 5 0.21), reflecting their instability.
Because there is no consensus about the most
appropriate tools for the validation of the best internal
control genes in a specific experimental condition, we
also validated the panel of eight genes by the Norm-
Finder algorithm (Andersen et al., 2004). This approach
examines the expression stability of each gene independ-
ently of other genes and tests combinations of gene pairs
to compensate for the variability of the system. The
NormFinder application estimates the variation in gene
Fig. 1. Expression level (Ct) of eight potential control genes tested in
cultured hippocampal neurons. The relative expression values of
rRNA 18S, Tuba1, Ppia, Gapdh, Pgk1, Hprt1, Tbp, and Actb was
determined under control conditions and in hippocampal neurons
stimulated with 100 ng/mL BDNF for 30 min or 3 hr. The data
points are the results of five independent transcription reactions per-
formed in independent preparations.
Fig. 2. Average expression stability values (M) during stepwise exclu-
sion of the least stable reference gene in the BDNF-stimulated cells,
resulting in the combination of the two most stable reference genes
by geNorm application. The highest M values correspond to least sta-
ble genes, Tuba1 and Gapdh, while the lowest M values correspond
to the most stable genes, Ppia and Hprt1. The raw data analyzed are
presented in Figure 1.
Fig. 3. Determination of the optimal number of reference genes for
normalization by pairwise variation (Vn/n 1 1) between the NFn
and NFn11 using the geNorm application. V2/3 is the addition of
Pgk1; V3/4 is the addition of Tbp; V4/5 is the addition of rRNA
18S; V5/6 is the addition of Actb; V6/7 is the addition of Gapdh;
and V7/8 is the addition of Tuba1. The raw data analyzed are
presented in Figure 1.
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expression, taking into account and avoiding variation
across subgroups. The stability value calculated by
NormFinder is a direct measure of expression variation,
allowing us to evaluate the systemic error introduced
when the selected genes are used for normalization
(Andersen et al., 2004). The main difference between
NormFinder and geNorm is that NormFinder selects the
best gene taking into account the experimental condi-
tions used; it also selects the best combination of gene
pair in order to compensate for fluctuation in the experi-
mental data. The variability of each one of the eight
genes tested is shown in Figure 4. NormFinder selected
Pgk1 as the gene that showed smaller intergroup varia-
tion, indicating that Pgk1 displayed the least variability in
experiments testing the effect of BDNF in cultured hip-
pocampal neurons. Tbp expression also showed low vari-
ability as determined with NormFinder, and therefore,
the combination of Tbp and Pgk1 is recommended by
this algorithm to compensate for fluctuation of experi-
mental data on changes in gene expression in response
to BDNF stimulation. The NormFinder algorithm avail-
able in the GenEx package (MultiD Analysis) also allows
for the determination of the optimal number of control
genes to be used in the normalization processes, through
the calculation of the accumulated standard deviation
(Acc. SD). The Acc. SD of the eight potential genes
tested is shown in Figure 5. The optimal number of en-
dogenous control genes is indicated by the minimal
value for the accumulated standard deviation, 0.31,
achieved when the six endogenous control genes that
show greater stability are used.
Comparison of the ranking of expression stability
for the eight reference genes tested in hippocampal neu-
rons subjected to stimulation with BDNF, as determined
by the geNorm (Fig. 2) and NormFinder (Fig. 4) algo-
rithms, shows that the most appropriate pair of reference
genes identified by each of the methods is distinct (Ppia,
Hprt1; Pgk1, Tbp for geNorm and NormFinder, respec-
tively). However, in both cases, the most variable genes
were those that are more often used as reference genes
(Tuba1, Gapdh, and Actb).
We have compared two sets of genes, Tuba1/
Gapdh/Actb (least stable genes) and Pgk1/Tbp/Ppia/Hprt1
(most stable genes), for normalization of BDNF-induced
changes in gene expression in cultured hippocampal
neurons. The two sets of genes were grouped on the
basis of their stability in BDNF-stimulated hippocampal
neurons (see above). Figure 6 shows the effect of BDNF
on the expression of two genes coding for proteins
belonging to the translation machinery, seryl-aminoacyl-
tRNA synthetase (Sars) and Tu mitochondrial translation
factor (Tufm), and early growth response 3 (Egr3). Sars is
an RNA binding protein responsible for the catalytic
transfer of L-serine to tRNA and Tufm is involved in
the chain formation during polypeptide synthesis at the
ribosome. When normalization was performed with the
genes showing the least variability (Pgk1, Tbp, Ppia and
Hprt1; Fig. 6A) statistically significant effects (P < 0.05)
of BDNF were found on the expression of Tufm (P 5
0.020) and Egr3 (P 5 0.012), with the former gene
showing a decrease in expression level and the latter
being upregulated. The effect of BDNF on the expres-
sion of Egr3 in cultured hippocampal neurons is in
agreement with a previous report (Roberts et al., 2006).
In contrast, no significant effects of BDNF on the
expression of Sars, Tufm or Egr3 were found when nor-
malization was performed with the genes showing higher
variability (Fig. 6D). Although both normalization pro-
cedures showed an upregulation of Sars in BDNF-
treated hippocampal neurons, the differences were not
statistically significant. Interestingly, normalization with
the most stable set of genes showed a downregulation of
Tufm expression, in contrast to the slight increase in
expression observed when the least stable genes were
used.
Fig. 4. Ranking of stability of reference gene expression, as deter-
mined by NormFinder. The variability of the tested control genes
was calculated in samples from hippocampal neurons stimulated (30
min or 3 hr) or not with 100 ng/mL BDNF. The algorithm selected
Pgk1 as the most stable gene and Pgk1 and Tbp as the most stable
gene pair, which shows the minimal inter- and intragroup variation.
The raw data analyzed are presented in Figure 1.
Fig. 5. Determination of the optimal number of reference genes for
normalization based on the calculation of the Acc. SD. Data analysis
was performed by NormFinder, an application available in the
GenEx software. The lowest value for the Acc. SD was achieved
when using the best six ranked reference genes (Acc. SD 5 0.31).
The raw data analyzed are presented in Figure 1.
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To determine how the number of reference genes
used in the normalization process affects the calculated
BDNF-induced changes in gene expression, we further
analyzed the results using two or three genes in the nor-
malization. The use of the three most stable genes (Pgk1,
Tbp, Ppia; Fig. 6B) in the normalization gave results sim-
ilar to those obtained when four genes were used (Fig.
6A). In contrast, when two genes were used for normal-
ization (Ppia and Pgk1; Fig. 6C) the effect of BDNF on
the expression level of Egr3 was even more significant (P
5 0.009). The effect of BDNF on both Sars and Tufm
expression levels was not changed when Ppia and Pgk1
were used as reference genes.
DISCUSSION
Reference genes are frequently used to normalize
qRT-PCR results (Vandesompele et al., 2002; Ayers
et al., 2007). Their use as normalizer genes has been
accepted as they are thought to be constitutively
expressed and invariable. However, several reports have
shown that commonly used reference genes can indeed
be differentially expressed among different tissues, in dif-
ferent developmental stages, and in distinct experimental
conditions (Thellin et al., 1999; Suzuki et al., 2000;
Glare et al., 2002; Sindelka et al., 2006, 2007). In the
present study, we tested the expression stability of a
panel of eight potential endogenous control genes in
control and BDNF-stimulated hippocampal neurons.
The genes tested are constitutively expressed in the cells
and have independent functions. Although the geNorm
and NormFinder algorithms provided distinct results
concerning the most stably expressed genes in BDNF-
treated hippocampal neurons (Ppia, Hprt1; Pgk1, Tbp,
respectively), both showed a higher variability in the
expression of genes often used as control genes (Tuba1,
Gapdh, and Actb). These results show that a careful selec-
tion of the genes used for normalization is required for
each experimental protocol. Because different methods
of analysis of gene expression provided distinct results
concerning the most stably expressed genes in cultured
hippocampal neurons subjected to stimulation with
BDNF (Figs. 3 and 5), a combination of at least three
genes from the group—Ppia, Pgk1, Hprt1, and Tbp—
should be used as a control (however, see below for fur-
ther discussion).
Several tools, including geNorm (Vandesompele
et al., 2002) and NormFinder (Andersen et al., 2004),
have been developed to identify the most stable genes.
Fig. 6. Effect of BDNF on the expression of Sars, Tufm, and Egr3, as
influenced by the sets of genes used for normalization. Hippocampal
neurons were stimulated or not with 100 ng/mL BDNF for 3 hr.
Normalization with the four (A: Pgk1, Tbp, Ppia, and Hprt1), three
(B: Pgk1, Tbp, and Ppia) and two (C: Pgk1 and Ppia) best ranked
control genes in BDNF stimulated hippocampal neurons are shown.
Normalization with the worst scoring control genes Tuba1, Gapdh,
and Actb is shown in panel D. The average Ct values obtained for
Sars, Tufm, and Egr3 were 24.12 6 1.32, 25.69 6 0.53, and 30.76 6
2.32, respectively. The results are the average 6 SEM of four inde-
pendent transcription reactions, performed in independent prepara-
tions. *P < 0.05, **P < 0.01 as determined by Student’s t-test per-
formed on log-transformed expression data.
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In the present work, we found that the use of the two
algorithms provided different results concerning the most
stable genes in cultured hippocampal neurons subjected
to stimulation with BDNF. Similar discrepancies were
also found in the selection of control genes for relative
quantification of gene expression during differentiation
of human embryonic stem (ES) cells, as well as in differ-
entiated mouse ES cells and in developing mouse
embryo (Willems et al., 2006). These differences
between the results obtained with the geNorm and
NormFinder algorithms may be explained on the basis
of the distinct mathematical approaches used. geNorm
tends to select the pair of genes with the highest degree
of similarity in the expression pattern, in contrast to
NormFinder that ranks first the genes with minimal
inter- and intragroup variation (Andersen et al., 2004).
This renders geNorm more sensitive to coregulated
genes than NormFinder, which analyses the expression
stability of each gene independently.
geNorm is based in the assumption that the expres-
sion ratio of two ideal reference genes is constant across
every sample (Vandesompele et al., 2002), ranking the
genes on the basis of their expression-stability value, M,
with highest M value corresponding to less stable genes.
By using samples from control and BDNF-treated hip-
pocampal neurons, we found that the most stable genes,
corresponding to the lowest M value, were Ppia and
Hprt1. Interestingly, Tuba1, Gapdh, and Actb, which are
widely used as reference genes, were ranked as the least
stable control genes in BDNF-stimulated cells. This
algorithm also calculates the NF value, which indicates
the optimal number of control genes to be used, and
cutoff values of 0.20 (Ayers et al., 2007) to 0.15 (Vande-
sompele et al., 2002; Spinsanti et al., 2006) have been
suggested. Because there is no standard value for NF,
our results suggest that the use of the three most stable
genes (Ppia, Hprt1, and Pgk1) is sufficient for an accurate
normalization process in studies regarding the BDNF-
induced changes in gene expression. It is interesting to
note that the expression of Gapdh and Pgk1, two genes
coding for glycolytic enzymes, show distinct patterns of
regulation in response to BDNF stimulation, Pgk1 being
more stable.
In this work, we also used NormFinder (Andersen
et al., 2004) to validate the putative control genes in
BDNF-stimulated cultured hippocampal neurons. By
using this algorithm, we identified Pgk1 as the most sta-
ble gene and Pgk1-Tbp as the best combination of genes,
showing the least variation across the subgroups. Fur-
thermore, Tuba1 and Gapdh, two commonly used refer-
ence genes, showed the least expression stability of all
control genes tested, in agreement with the results
obtained with the geNorm (Fig. 2). Therefore, the use
of Tuba1 and Gapdh as reference genes in studies on the
regulation of gene expression by BDNF in hippocampal
neurons should be avoided. With the NormFinder
approach, we calculated the Acc. SD of the tested genes,
and we found that the use of the six more stable endog-
enous control genes is recommended by this program
for the normalization processes. However, there was a
minor difference between using three (SD 5 0.32) or
six (SD 5 0.31) endogenous control genes, indicating
that the three more stable genes calculated by Norm-
Finder can safely be used in the normalization process.
The use of seven and eight endogenous control genes
(Gapdh and Tuba1) would not improve the normaliza-
tion, as the Acc. SD increases when these genes are
taken into account in the calculation of the Acc. SD.
When we compared the results from the pairwise
variations graph and Acc. SD graph, both geNorm and
NormFinder gave the same results, with the minimal
value for the NF achieved when the six best-ranked
genes were included, and the Acc. SD was also minimal
when the six more stable genes were considered for nor-
malization. The minimum number of endogenous con-
trol genes to be used for normalization in gene expres-
sion studies is still under debate; it is necessary to balance
the need of using multiple control genes with economi-
cal and practical considerations.
The importance of a valid and proper normaliza-
tion process is clearly shown by the results of Figure 6,
where the normalization of the BDNF-induced changes
in gene expression was performed by using four different
sets of genes. The conclusions that can be drawn about
the effects of BDNF in hippocampal neurons depend on
how accurate the normalization process is, especially
when dealing with small changes in gene expression.
Taken together, the results obtained by geNorm and
NormFinder and the tests that used three target genes
indicate that three reference genes can safely be used for
normalization, leading to accurate and reliable results.
Surprisingly, normalization with only two reference
genes slightly increased the statistical significance of the
BDNF-induced changes in Egr3 expression. However,
caution should be used whenever normalizing results
with only two reference genes.
In conclusion, our results point out the importance
of prior verification of the expression stability of the en-
dogenous control genes in each specific setup and the
need of using multiple valid endogenous control genes
for an accurate normalization of the results. This is
particularly relevant when analyzing cellular responses to
agents, such as neurotrophins, that cause multiple
changes in gene expression.
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